The manufacture and release of mRNA therapeutics and vaccines is a complex and challenging process that requires a high degree of expertise, capabilities, and experience. The production process involves several stages, including the production of cell banks, linear DNA, mRNA drug substance, LNP encapsulation, fill/finish, and analytical testing at all steps. Each production stage must be executed flawlessly to ensure the final product's safety and efficacy. Furthermore, when working with multiple contract development and manufacturing organizations (CDMOs), the management of logistics, tech transfer, release testing, shipping, storage, and analytical testing becomes complex and requires unyielding project management. Aldevron has overcome this challenge by offering a comprehensive mRNA production ecosystem with sequence to vial capabilities under one-roof, thereby eliminating the unnecessary complexities of multiple CDMOs exchanges and accelerating the program timeline.
